2027 ICD-10-CM Diagnosis Code G70.00Myasthenia gravis without (acute) exacerbation

ICD-10-CM Codes›G00–G99›G70-G73›G70

ICD-10-CM G70.00
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

G70.00 is a billable ICD-10-CM diagnosis code for myasthenia gravis without (acute) exacerbation. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 56 through 57. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Myopathies.

For Medicare Advantage risk adjustment, G70.00 maps to CMS-HCC Category 196 (Myasthenia Gravis without (Acute) Exacerbation and Other Myoneural Disorders) under the V28 model, adding a risk factor of about 0.516 for a community, non-dual, aged beneficiary in payment year 2027.

Code Identity

ICD-10-CM Code
G70.00
Billable Status
Yes — Valid for Submission
Code Describes
Myasthenia gravis without (acute) exacerbation
Short Description
Myasthenia gravis without (acute) exacerbation
Same as the full description in the CMS dataset.
Parent Code
Myasthenia gravis

Code Classification

ChapterG00–G99Diseases of the nervous system
SectionG70-G73Diseases of myoneural junction and muscle
CategoryG70Myasthenia gravis and other myoneural disorders
This CodeG70.00Myasthenia gravis without (acute) exacerbation

Medicare Risk Adjustment (HCC)Billing

G70.00 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2027.

CMS-HCC V28 Category (Payment Model)
HCC 196— Myasthenia Gravis without (Acute) Exacerbation and Other Myoneural Disorders
Payment HCC · PY 2027 one of 9 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.516
community, non-dual, aged · ranges 0.248–0.642 across segments
Hierarchy
Superseded by HCC 195
a more severe related category takes the payment when both are reported
Prior Model (CMS-HCC V24)
HCC 75
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 75 · ESRD (V21): HCC 75 · ESRD (V24): HCC 75
ESRD V21 weights: 0.059 dialysis, 0.284–0.323 functioning graft · ESRD V24 weights: 0.074 dialysis, 0.344–0.599 functioning graft
Part D (RxHCC)
RxHCC 153 — Myasthenia Gravis and Other Myoneural Disorders
also risk-adjusts in the Part D prescription drug model (V08)

Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Abnormality of synaptic vesicles
  • Congenital end-plate acetylcholinesterase deficiency
  • Congenital myasthenic syndrome
  • Decrease of motor end-plate potential amplitude without acetylcholine receptor deficiency
  • Deficiency of acetylcholinesterase
  • Generalized myasthenia
  • Genetically determined myasthenia
  • Juvenile or adult myasthenia gravis
  • Myasthenia gravis
  • Myasthenia gravis associated with thymoma
  • Myasthenia gravis caused by MuSK antibodies
  • Myasthenia gravis in remission
  • Myasthenia gravis without exacerbation
  • Myasthenia gravis, adult form
  • Myasthenia gravis, juvenile form
  • Myopathy in myasthenia gravis
  • Neonatal myasthenia gravis
  • Neonatal neuromuscular disorder
  • Ocular myasthenia
  • Ocular myasthenia with strabismus
  • Persistent neonatal myasthenia gravis
  • Putative defect in acetylcholine synthesis or packaging
  • Rippling muscle disease
  • Rippling muscle disease with myasthenia gravis
  • Toxic neuromuscular junction disorder

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to G70.00: its own notes plus those printed at G70 and Chapter 6. A note printed at a category, block or chapter applies to every code under it.

Applicable To

Conditions this code is used for: synonyms of the title or, for "other specified" codes, the conditions assigned to it. The list is not exhaustive.

  • Myasthenia gravis NOS

Excludes1

Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.

From G70 Myasthenia gravis and other myoneural disorders applies to 8 codes

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From Chapter 6 (G00-G99) Diseases of the nervous system applies to 700 codes
  • certain conditions originating in the perinatal period (P04-P96)
  • certain infectious and parasitic diseases (A00-B99)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name G70.00, its category, or a range that includes it.

Excludes1 2

These codes carry an Excludes1 note naming G70.00: they are not reported together with it, unless the two conditions are unrelated.

  • E32 Diseases of thymus
    myasthenia gravis (G70.0) names G70.0, which includes this code
  • P94.0 Transient neonatal myasthenia gravis
    myasthenia gravis (G70.0) names G70.0, which includes this code

Index to Diseases and InjuriesGuidance

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NVS018
Myopathies
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Myasthenia Gravis

    a disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of acetylcholine receptors or muscle-specific receptor tyrosine kinase (musk) autoantibodies. clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. the disease may remain limited to the ocular muscles (ocular myasthenia). thymoma is commonly associated with this condition.

Patient EducationClinical

Myasthenia Gravis

Myasthenia gravis, sometimes called MG, is a chronic (long-lasting) disease that causes weakness in your voluntary muscles. The voluntary muscles are the ones that you can control. They include the muscles you use for:

The full article covers:

  • What is myasthenia gravis?
  • What causes myasthenia gravis?
  • Who is more likely to develop myasthenia gravis?
  • What are the symptoms of myasthenia gravis?
  • How is myasthenia gravis diagnosed?
  • What are the treatments for myasthenia gravis?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert G70.00 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
358.00 Mysthna grvs w/o ac exac
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About G70.00Overview

What is the ICD-10 code for myasthenia gravis without (acute) exacerbation?

The ICD-10-CM code for myasthenia gravis without (acute) exacerbation is G70.00 (sometimes written as G7000). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

Is G70.00 (Myasthenia gravis) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report myasthenia gravis without (acute) exacerbation on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What MS-DRG does G70.00 group to?

When myasthenia gravis without (acute) exacerbation is the principal diagnosis on an inpatient stay, it groups to MS-DRG 57, 56, with relative weights from 1.2835 to 2.2649 depending on complications. Higher weights mean higher Medicare reimbursement.

Can G70.00 be reported with A05.1?

Not as a rule. The Excludes1 note at G70, which applies to G70.00, lists "botulism (A05.1, A48.51-A48.52)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).

What is the ICD-9 equivalent of G70.00?

Under the General Equivalence Mappings, myasthenia gravis without (acute) exacerbation converts to ICD-9-CM 358.00 (mysthna grvs w/o ac exac). The mapping is a direct match.

What HCC is G70.00?

G70.00 (myasthenia gravis without (acute) exacerbation) maps to CMS-HCC Category 196 (Myasthenia Gravis without (Acute) Exacerbation and Other Myoneural Disorders), commonly written as HCC 196, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2027. It mapped to HCC 75 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. In the Part D prescription drug model it maps to RxHCC 153.

Does G70.00 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, G70.00 adds a risk adjustment factor of about 0.516 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.248 to 0.642 depending on the payment segment). A more severe related category (HCC 195) supersedes it when both are reported. See the full factor table on the HCC 196 category page.